The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index; 18 of the 33 sources its claims cite were checked for support.
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
Open accessAbstract
The CONSORT 2010 statement provides minimum guidelines for reporting randomized trials. Its widespread use has been instrumental in ensuring transparency in the evaluation of new interventions. More recently, there has been a growing recognition that interventions involving artificial intelligence (AI) need to undergo rigorous, prospective evaluation to demonstrate impact on health outcomes. The CONSORT-AI (Consolidated Standards of Reporting Trials–Artificial Intelligence) extension is a new reporting guideline for clinical trials evaluating interventions with an AI component. It was developed in parallel with its companion statement for clinical trial protocols: SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials–Artificial Intelligence). Both guidelines were developed through a staged consensus process involving literature review and expert consultation to generate 29 candidate items, which were assessed by an international multi-stakeholder group in a two-stage Delphi survey (103 stakeholders), agreed upon in a two-day consensus meeting (31 stakeholders) and refined through a checklist pilot (34 participants). The CONSORT-AI extension includes 14 new items that were considered sufficiently important for AI interventions that they should be routinely reported in addition to the core CONSORT 2010 items. CONSORT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention is integrated, the handling of inputs and outputs of the AI intervention, the human–AI interaction and provision of an analysis of error cases. CONSORT-AI will help promote transparency and completeness in reporting clinical trials for AI interventions. It will assist editors and peer reviewers, as well as the general readership, to understand, interpret and critically appraise the quality of clinical trial design and risk of bias in the reported outcomes.
Overview
CoChat Summary
TL;DR
CONSORT-AI is a reporting-guideline extension that adds 14 AI-specific items to the CONSORT 2010 checklist for randomized trials of interventions involving artificial intelligence. It was developed through literature review, a two-stage Delphi survey, a consensus meeting, and a checklist pilot to improve transparency and completeness in AI trial reports.
Key findings
- The CONSORT-AI extension includes 14 new checklist items (11 extensions and 3 elaborations) considered sufficiently important for AI interventions to be routinely reported alongside core CONSORT 2010 items.
- The development process generated 29 candidate items; the two-stage Delphi survey received 103 responses in round one and 91 responses in round two (88% of round-one participants), and the consensus meeting involved 31 stakeholders.
- The final checklist recommends clear reporting of the AI intervention, including instructions and skills required for use, integration setting, handling of inputs and outputs, human–AI interaction, and analysis of error cases.
- All 14 included items passed the pre-specified 80% inclusion threshold; CONSORT-AI 5(iii) initially received 77% support, then passed with 97% after rewording and a re-vote.
Methods
- CONSORT-AI was developed in parallel with SPIRIT-AI according to the EQUATOR Network’s methodological framework, overseen by a 15-member international Steering Group.
- A literature search on 13 May 2019 using “artificial intelligence,” “machine learning,” and “deep learning” identified 316 registered trials on ClinicalTrials.gov, of which 62 were completed and 7 had published results; after consultation with 19 experts, 29 candidate items were generated.
- Candidate items were assessed in a two-stage online Delphi survey (169 experts invited; 103 and 91 responses), discussed at a two-day consensus meeting in January 2020 (31 stakeholders; 41 items discussed; 80% inclusion threshold), and refined through a checklist pilot with 34 participants.
Limitations
- The authors state that relatively few published interventional AI trials existed, so discussions and decisions were not always supported by completed trial examples.
- The authors state that the literature search used terms such as “artificial intelligence,” “machine learning,” and “deep learning,” but not “clinical decision support systems” or “expert systems,” so such systems were not actively discussed.
- The authors state that initial candidate items were generated by a relatively small expert group, though wider Delphi participants proposed additional items; the text also makes evident that CONSORT-AI is a minimum reporting guidance and will need updating as AI applications evolve.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
9 Valid · 7 Not valid · 6 Not checked · 36 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“There are limitations to the generalizability of AI algorithms, one of which is when they are used outside of their development environment45,46.”
§ Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension > Methods > CONSORT-AI 4b Extension: Describe how the AI intervention was integrated into the trial setting, including any onsite or offsite requirements
What the sources say
- Supportedcites [45] Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G. & King, D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 17, 195 (2019). source
The ‘Challenges related to machine learning science’ section explicitly identifies inapplicability outside the training domain as a potential shortcoming of AI algorithms. The ‘Challenges in generalisation to new populations and settings’ section explains that differences between sites can make generalisation difficult. These passages support the claim about limitations when algorithms are used outside their development environment. (LLM, conf=0.94)
- Supportedcites [46] Pooch, E. H. P., Ballester, P. L. & Barros, R. C. Can we trust deep learning models diagnosis? The impact of domain shift in chest radiograph classification. arXiv http://arxiv.org/abs/1909.01940 (2019). source
The Discussion and Conclusion (p. 8) reports a large performance drop when a chest-radiograph model was tested outside its source dataset. The Introduction (p. 2) identifies testing on data from other hospitals or diagnostic centers as a test of generalizability. This supports the cited point that use outside a model’s development environment can limit generalizability. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The welcome emergence of RCTs seeking to evaluate newer interventions based on, or including, an AI component (called ‘AI interventions’ here)23,26–31 has similarly been met with concerns about the design and reporting25,32–34.”
§ Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension > Main
What the sources say
- Not checked — no full text of the sourcecites [25] Liu, X. et al. A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis. Lancet Digit. Health 1, e271–e297 (2019). source
- Not checked — no full text of the sourcecites [32] Collins, G. S. & Moons, K. G. M. Reporting of artificial intelligence prediction models. Lancet 393, 1577–1579 (2019). source
- Not checked — no full text of the sourcecites [33] Gregory, J., Welliver, S. & Chong, J. Top 10 reviewer critiques of radiology artificial intelligence (AI) articles: qualitative thematic analysis of reviewer critiques of machine learning/deep learning manuscripts submitted to JMRI. J. Magn. Reson. Imaging 52, 248–254 (2020). source
- Partly supportedcites [34] Nagendran, M. et al. Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies. Br. Med. J. 368, m689 (2020). sourceExperimental — accuracy not yet measured
The Discussion raises concerns about the design and reporting of deep-learning studies comparing diagnostic AI with clinicians, and the Methods say the review assessed reporting and risk of bias in randomised studies. Its scope was diagnostic medical imaging, however; the Study limitations caution against generalising its findings to other types of AI. It therefore supports the concern for the RCTs it reviewed, but not for AI-intervention RCTs generally (section-labelled copy; no page numbers supplied). (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“changes to medical imaging that are invisible, or appear random, to the human eye may change the likelihood of the diagnostic output entirely55,56.”
§ Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension > Discussion
What the sources say
- Partly supportedcites [55] Zech, J. R. et al. Confounding variables can degrade generalization performance of radiological deep learning models. arXiv http://arxiv.org/abs/1807.00431 (2018). sourceExperimental — accuracy not yet measured
The Discussion (p. 12) says CNNs may rely on subtle differences in image acquisition or processing rather than pathology, and that identifying features became apparent to the authors only after manual review. It does not establish that changes invisible or random-looking to the human eye alter a diagnostic output; its finding concerns confounding features across radiographs and their effect on predictions and generalization. (LLM, conf=0.84)
- Supportedcites [56] Finlayson, S. G. et al. Adversarial attacks on medical machine learning. Science 363, 1287–1289 (2019). source
In DEEP VULNERABILITIES, the paper describes a perturbation that appears to be random noise but is visually imperceptible when added to a medical image. It reports that the altered image changed a classifier’s output from benign with over 99% confidence to malignant with 100% confidence. (LLM, conf=0.94)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
In the paper
“The measured performance of any AI system may be critically dependent on the nature and quality of the input data48.”
§ Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension > Methods > CONSORT-AI 5 (ii) Extension: Describe how the input data were acquired and selected for the AI intervention
What the sources say
- Not checked — no full text of the sourcecites [48] Sabottke, C. F. & Spieler, B. M. The effect of image resolution on deep learning in radiography. Radiology: Artif. Intell. 2, e190015 (2020). source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“AI systems are dependent on their operational environment, and the report should provide details of the hardware and software requirements to allow technical integration of the AI intervention at each study site.”
§ Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension > Methods > CONSORT-AI 4b Extension: Describe how the AI intervention was integrated into the trial setting, including any onsite or offsite requirements
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
3 more claims
Create a free account to see all 58 claims and every source verdict.
- Probably not a substantial claim. 45
- It may state two separate claims as one. 16
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The CONSORT-AI and SPIRIT-AI extensions, developed to bring rigor to the prospective evaluation of AI interventions, codify many of these expectations and provide a framework that oncology investigators and journals are increasingly adopting.61”
From Artificial Intelligence in Oncology: Practical Applications Across Clinical Care, Scholarship, and Translation. (2026) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, the analysis of error cases is a minimum reporting requirement of the SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence) and CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence) guidelines for clinical trial protocols and reports of artificial intelligence interventions.7,8”
From The medical algorithmic audit (2022) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Effective collaboration is further emphasized by Liu et al. (2020) [35], who demonstrated that successful AI integration in healthcare settings relies on well-designed interfaces and communication strategies that align with clinical workflows.”
From Leading with AI in critical care nursing: challenges, opportunities, and the human factor (2024) · cites this paper as Liu et al. (2020) [35]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Of the 63 trials published since the start of 2021, 12 (19%) cited the 2020 CONSORT-AI reporting guidelines for clinical trials assessing AI interventions.16”
From Randomised controlled trials evaluating artificial intelligence in clinical practice: a scoping review (2024) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“A number of comprehensive frameworks and checklists have been developed, such as the Translational Evaluation of Healthcare AI (TEHAI) [46], the DECIDE-AI [47], the Consolidated Standards of Reporting Trials-Artificial Intelligence (CONSORT-AI) [48], the prediction model risk of bias assessment tool (PROBAST) [49], and the Checklist for AI in Medical Imaging (CLAIM) [50].”
From Bias in artificial intelligence algorithms and recommendations for mitigation (2023) · cites this paper as [48]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension > Recommendations > CONSORT-AI checklist items and explanation
“bIndicates page numbers to be completed by authors during protocol development.”
§ Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension > Recommendations > CONSORT-AI checklist items and explanation
“These items were considered sufficiently important for clinical-trial reports for AI interventions that they should be routinely reported in addition to the core CONSORT 2010 checklist items. Table 1 lists the CONSORT-AI items.”
Citations
Cites
Dermatologist-level classification of skin cancer with deep neural networks
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362
Self-citationMoher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Self-citationSchulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
International evaluation of an AI system for breast cancer screening
McKinney, S. M., Sieniek, M., Godbole, V., Godwin, J., Antropova, N., Ashrafian, H., Back, T., Chesus, M., Corrado, G. S., Darzi, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1799-6 · Cited by 3,287
Self-citationKey challenges for delivering clinical impact with artificial intelligence
Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D. (2019) · BMC Medicine · doi:10.1186/s12916-019-1426-2 · Cited by 3,136
Self-citationAn overview of clinical decision support systems: Benefits, risks, and strategies for success
Sutton, R. T., Pincock, D., Baumgart, D. C., Sadowski, D. C., Fedorak, R. N., & Kroeker, K. I. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0221-y · Cited by 3,019
Clinically applicable deep learning for diagnosis and referral in retinal disease
De Fauw, J., Ledsam, J. R., Romera-Paredes, B., Nikolov, S., Tomasev, N., Blackwell, S., Askham, H., Glorot, X., O’Donoghue, B., Visentin, D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0107-6 · Cited by 2,639
Self-citationThe practical implementation of artificial intelligence technologies in medicine
He, J., Baxter, S. L., Xu, J., Xu, J., Zhou, X., & Zhang, K. (2019) · Nature Medicine · doi:10.1038/s41591-018-0307-0 · Cited by 2,246
Liu, X., Faes, L., Kale, A. U., Wagner, S. K., Fu, D. J., Bruynseels, A., Mahendiran, T., Moraes, G., Shamdas, M., Kern, C., et al. (2019) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30123-2 · Cited by 1,883
Self-citation
Cited by
Artificial intelligence and deep learning in ophthalmology
Ting, D. S. W., Pasquale, L. R., Peng, L., Campbell, J. P., Lee, A. Y., Raman, R., Tan, G. S. W., Schmetterer, L., Keane, P. A., & Wong, T. Y. (2019) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2018-313173 · Cited by 1,554
Self-citationArtificial Intelligence and Deep Learning in Ophthalmology
Wang, Z., Keane, P. A., Chiang, M., Cheung, C. Y., Wong, T. Y., & Ting, D. S. W. (2022) · Artificial Intelligence in Medicine · doi:10.1007/978-3-030-64573-1_200 · Cited by 1,524
Self-citationArtificial Intelligence and Machine Learning in Clinical Medicine, 2023
Haug, C. J., & Drazen, J. M. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2302038 · Cited by 1,215
Self-citationDiagnostic accuracy of deep learning in medical imaging: a systematic review and meta-analysis
Aggarwal, R., Sounderajah, V., Martin, G., Ting, D. S. W., Karthikesalingam, A., King, D., Ashrafian, H., & Darzi, A. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00438-z · Cited by 946
Self-citationVasey, B., Nagendran, M., Campbell, B., Clifton, D. A., Collins, G. S., Denaxas, S., Denniston, A. K., Faes, L., Geerts, B., Ibrahim, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01772-9 · Cited by 1,039
Self-citation
Metadata
- Authors
- Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J., Denniston, A. K., The SPIRIT-AI and CONSORT-AI Working Group, SPIRIT-AI and CONSORT-AI Steering Group, Chan, A.-W., Darzi, A., Holmes, C., Yau, C., Ashrafian, H., Deeks, J. J., Ferrante di Ruffano, L., Faes, L., Keane, P. A., Vollmer, S. J., SPIRIT-AI and CONSORT-AI Consensus Group, Lee, A. Y., Jonas, A., Esteva, A., Beam, A. L., Chan, A.-W., Panico, M. B., Lee, C. S., Haug, C., Kelly, C. J., Yau, C., Mulrow, C., Espinoza, C., Fletcher, J., Paltoo, D., Manna, E., Price, G., Collins, G. S., Harvey, H., Matcham, J., Monteiro, J., ElZarrad, M. K., Ferrante di Ruffano, L., Oakden-Rayner, L., McCradden, M., Keane, P. A., Savage, R., Golub, R., Sarkar, R., & Rowley, S.
- Affiliations
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Ottawa (CA)
- University of Toronto (CA)
- Imperial College London (GB)
- The Alan Turing Institute (GB)
- University of Oxford (GB)
- Luzerner Kantonsspital (CH)
- National Institute for Health and Care Excellence (GB)
- Salesforce (United States) (US)
- Harvard University (US)
- Google (United Kingdom) (GB)
- University of Washington (US)
- National Institutes of Health (US)
- BMJ Group (United Kingdom) (GB)
- AstraZeneca (United Kingdom) (GB)
- United States Food and Drug Administration (US)
- American Medical Association (US)
- Medical Research Council (GB)
- Corresponding author
- Denniston, Alastair K.
- ORCID
- Liu, Xiaoxuan
- Moher, David
- Calvert, Melanie J.
- Denniston, Alastair K.
- Darzi, Ara
- Holmes, Christopher
- Ashrafian, Hutan
- Deeks, Jonathan J.
- Faes, Livia
- Vollmer, Sebastian J.
- Lee, Aaron Y.
- Esteva, Andre
- Beam, Andrew L.
- Lee, Cecilia S.
- Haug, Charlotte
- Kelly, Christopher J.
- Mulrow, Cynthia
- Fletcher, John
- Harvey, Hugh
- ElZarrad, M. Khair
- McCradden, Melissa
- Savage, Richard
- Sarkar, Rupa
- Rowley, Samuel
- Venue
- Nature Medicine
- Published
- 2020-09
- Volume
- 26
- Issue
- 9
- Pages
- 1364-1374
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC7598943
- OpenAlex
- W3136552952
- Cited by
- 1,421
- References
- 60
- Citations by year
- 2026: 596 · 2025: 243 · 2024: 162 · 2023: 129 · 2022: 145 · 2021: 129 · 2020: 16
- FWCI
- 21.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 8 d)
- Locations
- Nature Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (acceptedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Wellcome Trust
- Alan Turing Institute
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Keywords
- CONSORT-AI, reporting guidelines, artificial intelligence interventions, clinical trial reporting, human-AI interaction, risk of bias
- MeSH terms
- Artificial Intelligence, Humans, Research Design, Randomized Controlled Trials as Topic, Peer Review, Research, Research Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. https://app.cochat.ai/papers/10.1038/s41591-020-1034-x
- The paper
- Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J., Denniston, A. K., The SPIRIT-AI and CONSORT-AI Working Group, SPIRIT-AI and CONSORT-AI Steering Group, Chan, A.-W., Darzi, A., Holmes, C., Yau, C., Ashrafian, H., Deeks, J. J., Ferrante di Ruffano, L., Faes, L., Keane, P. A., Vollmer, S. J., SPIRIT-AI and CONSORT-AI Consensus Group, Lee, A. Y., . . . Rowley, S. (2020). Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nature Medicine. https://doi.org/10.1038/s41591-020-1034-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.